We are live on ! Find out more
RBC

Roble Belko & Company Portfolio holdings

AUM $925M
1-Year Est. Return 19.7%
This Fund
S&P 500
This Quarter Est. Return
+16.84%
1 Year Est. Return
+19.7%
3 Year Est. Return
+53.27%
5 Year Est. Return
+47.85%
10 Year Est. Return
+149.75%
AUM
$334M
AUM Growth
+$24.3M
Cap. Flow
-$24.6M
Cap. Flow %
-7.37%
Top 10 Hldgs %
54.8%
Holding
349
New
15
Increased
35
Reduced
73
Closed
25

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 1.99%
2 Technology 1.72%
3 Healthcare 0.91%
4 Industrials 0.77%
5 Financials 0.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEE icon
51
NextEra Energy
NEE
$179B
$447K 0.13%
7,444
MRK icon
52
Merck
MRK
$317B
$415K 0.12%
5,625
+423
+8% +$31.8K
IWD icon
53
iShares Russell 1000 Value ETF
IWD
$83.2B
$405K 0.12%
3,598
-192
-5% -$21.1K
JNJ icon
54
Johnson & Johnson
JNJ
$621B
$388K 0.12%
2,762
+208
+8% +$30.3K
UPS icon
55
United Parcel Service
UPS
$91.5B
$381K 0.11%
3,424
AMZN icon
56
Amazon
AMZN
$2.94T
$361K 0.11%
2,620
ACN icon
57
Accenture
ACN
$104B
$353K 0.11%
1,645
DUK icon
58
Duke Energy
DUK
$96.2B
$349K 0.1%
4,364
VO icon
59
Vanguard Morningstar Mid-Cap ETF
VO
$109B
$344K 0.1%
8,404
ACWX icon
60
iShares MSCI ACWI ex US ETF
ACWX
$11.8B
$333K 0.1%
7,699
-2,044
-21% -$83.5K
MDY icon
61
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27B
$323K 0.1%
994
+975
+5,132% +$296K
FLRN icon
62
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$3.09B
$322K 0.1%
10,569
-653
-6% -$19.7K
IUSV icon
63
iShares Core S&P US Value ETF
IUSV
$27.6B
$306K 0.09%
5,864
XBI icon
64
State Street SPDR S&P Biotech ETF
XBI
$9.99B
$303K 0.09%
2,710
-3,055
-53% -$301K
UFOX
65
Defiance Space and Connective Tech ETF
UFOX
$888M
$301K 0.09%
11,040
-3,386
-23% -$85.6K
IBDQ
66
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
$286K 0.09%
10,584
IWR icon
67
iShares Russell Mid-Cap ETF
IWR
$57B
$282K 0.08%
5,262
IVW icon
68
iShares S&P 500 Growth ETF
IVW
$77.1B
$275K 0.08%
5,296
IBDP
69
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
$274K 0.08%
10,406
BRK.B icon
70
Berkshire Hathaway Class B
BRK.B
$1.12T
$271K 0.08%
1,519
-22
-1% -$4.02K
IBDR icon
71
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.39B
$270K 0.08%
10,105
HYT icon
72
BlackRock Corporate High Yield Fund
HYT
$1.37B
$265K 0.08%
26,026
+263
+1% +$2.54K
IBDS icon
73
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.84B
$264K 0.08%
9,779
+7,493
+328% +$195K
SCHH icon
74
Schwab US REIT ETF
SCHH
$11.4B
$264K 0.08%
14,970
-192,824
-93% -$3.35M
VCSH icon
75
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$264K 0.08%
3,189
+1,798
+129% +$146K

Similar funds

Roble Belko & Company's Q2 2020 Portfolio in Review

As of Q2 2020, Roble Belko & Company held 349 positions worth $334M, up 7.9% from $309M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Roble Belko & Company withdrew a net $24.6M in Q2 2020, closing 25 positions and reducing 73 holdings. Its most notable exit was Vanguard International High Dividend Yield ETF, an estimated $5.4M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 2% of assets, down from 2% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Roble Belko & Company opened a new position in iShares iBonds Dec 2028 Term Corporate ETF worth $262K.

  • Roble Belko & Company's largest Q2 2020 buy was iShares iBonds Dec 2028 Term Corporate ETF: 9,096 shares worth $262K.
  • Roble Belko & Company added most to State Street SPDR S&P Dividend ETF in Q2 2020, an estimated $3.69M increase.
  • Roble Belko & Company's biggest Q2 2020 reduction was Schwab US REIT ETF, cutting an estimated $3.35M.
  • Roble Belko & Company fully exited Vanguard International High Dividend Yield ETF in Q2 2020, selling an estimated $5.4M.
  • Roble Belko & Company's ten largest holdings make up 55% of its $334M portfolio in Q2 2020.
  • Roble Belko & Company opened 15 new positions and closed 25 in Q2 2020.
  • Roble Belko & Company's portfolio value rose 7.9% quarter-over-quarter to $334M.

Based on Roble Belko & Company's 13F filing for Q2 2020, filed 10 Aug 2020.